Article
Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
Journal of neurology - 1 Aug 2009
Fujita Masayo, Sekigawa Akio, Sekiyama Kazunari, Sugama Shuei, Hashimoto Makoto
Abstract excerpt
Many groups have generated alpha-synuclein (alpha-syn) transgenic (tg) mice as a rodent model for human synucleinopathies, including Parkinson's disease and dementia with Lewy bodies (DLB). Indeed, some of the lines displayed limited evidence of neurodegeneration, such as alpha-syn deposits, compromised function of dopaminergic neurons, fibrillization of alpha-syn, and astrogliosis. However, none of them fully...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
